University of Texas M. D. Anderson Cancer Center

The University of Texas M.D. Anderson Cancer Center is one of the original 3 cancer treatment centers established after the 1971 National Cancer Act. It is a degree awarding institution and is connected to the University of Texas Medical Centers in Houston. Today the M.D. Anderson Cancer Center is one of the finest cancer treatment and research hospitals rivaled only by the Sloan-Kettering Cancer Center in New York. There are approximately 36 other cancer treatment centers designated by the National Cancer Institute as cancer centers. It is a 512 bed hospital with a Level 1 Trauma Center that employs over 17,000 professionals and support staff. The M.D. Anderson Cancer Center offers fellowships, internships and residency opportunities. The Center can trace its inception to 1941 by virtue of an act of the Texas Legislature.

Think of a waterfall, and you might see why cell-signaling pathways are important to cancer research. As water cascades, it impacts everything downstream. And everything upstream affects the waterfall.

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

A protein which is intimately involved in cancer-promoting cell signaling also keeps a key component of the signaling pathway tied down and inactive, a team led by scientists from The University of Texas MD Anderson Cancer ...

Chromatin - the intertwined histone proteins and DNA that make up chromosomes  constantly receives messages that pour in from a cells intricate signaling networks: Turn that gene on. Stifle that one.

A protein known as WWP2 appears to play a key role in tumor survival, a research team headed by a scientist at The University of Texas MD Anderson Cancer Center reports in an advance online publication of Nature Cell Biology.

A common genetic variation links to both bladder cancer risk and to the length of protective caps found on the ends of chromosomes, scientists at The University of Texas MD Anderson Cancer Center reported today at the AACR ...

The University of Texas MD Anderson Cancer Center has been awarded a grant to study whether xerostomia, a debilitating side effect caused by head and neck cancer radiation treatment, can be prevented when acupuncture is part ...

Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical In ...

Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson ...

An essential protein for normal stem cell renewal also promotes the growth of breast cancer stem cells when it's overproduced in those cells, researchers at The University of Texas MD Anderson Cancer Center report in the ...

In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced pancreatic neuroendocrine ...

A $4 million, five-year grant from the National Cancer Institute will create a Texas regional Community Networks Program Center (CNPC), called Latinos Contra El Cancer, to reduce cancer-related health disparities among Texas ...